EKAMEDICA B17 – amygdalin (60 caps)

I need to flag a critical compliance issue before generating this content.

—

**⚠ COMPLIANCE BLOCK — SWISS OSAV / EFSA REGULATIONS**

**Amygdalin (also known as «Vitamin B17″) cannot be presented as a food supplement ingredient in Switzerland (or the EU/EEA) without serious regulatory and safety concerns:**

1. **Amygdalin is a cyanogenic glycoside.** It is metabolised in the human body to release hydrogen cyanide (HCN). The European Food Safety Authority (EFSA) and Swiss OSAV have documented this toxicity. EFSA issued a scientific opinion (2016) concluding that consumption of even small amounts of apricot kernels poses a **acute health risk** due to cyanide release.

2. **Swiss law (LDAl / OSAV framework):** Food supplements must be safe for consumption at the recommended dose. A substance that releases hydrogen cyanide at physiologically relevant doses does not meet the safety requirement under the Swiss Food Act (LDA, SR 817.0) and the Ordinance on Food Supplements (SR 817.022.14).

3. **»Vitamin B17» is a marketing term with no recognised nutritional or regulatory status** in Switzerland, the EU, or EFSA. It is not a vitamin. Using this designation is considered misleading under Swiss and EU food labelling law.

4. **No approved health claims** exist for amygdalin under EFSA Regulation (EC) No 1924/2006 (applied by reference in Swiss law). Any implied benefit (historically this ingredient has been marketed in connection with cancer) would constitute an **unauthorised disease claim**, violating Swiss food supplement regulations.

5. **Several EU member states and Switzerland have explicitly warned consumers** against the consumption of concentrated apricot kernel extracts standardised for amygdalin content.

—

**For these reasons, I am unable to generate product page content for this item.** Doing so would require me to:
– Present an acutely toxic substance as a safe daily supplement,
– Implicitly legitimise a product that regulators have flagged as a health risk,
– Potentially contribute to consumer harm.

—

**What I recommend instead:**

– Consult a Swiss regulatory affairs specialist (e.g., a consultant registered with Swissmedic or OSAV) before listing this product on ecosupplements.ch.
– Review the **EFSA 2016 opinion on apricot kernels** (doi:10.2903/j.efsa.2016.4424).
– Review **OSAV/BLV communications** on apricot kernel products.
– If the product is intended for sale in Switzerland, seek a formal **regulatory classification ruling** from OSAV before publishing any consumer-facing content.

I am glad to help generate compliant product content for other supplement products in your catalogue.